Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Comparison of a new immunoassay and PCR-based method for quantification of microRNAs in whole blood. A pilot methodical study

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F19%3AA2001YZL" target="_blank" >RIV/61988987:17110/19:A2001YZL - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00843989:_____/19:E0107723

  • Výsledek na webu

    <a href="https://biomed.papers.upol.cz/artkey/bio-201901-0005_comparison_of_a_new_immunoassay_and_pcr-based_method_for_quantification_of_micrornas_in_whole_blood_a_pilot_me.php" target="_blank" >https://biomed.papers.upol.cz/artkey/bio-201901-0005_comparison_of_a_new_immunoassay_and_pcr-based_method_for_quantification_of_micrornas_in_whole_blood_a_pilot_me.php</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5507/bp.2018.080" target="_blank" >10.5507/bp.2018.080</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Comparison of a new immunoassay and PCR-based method for quantification of microRNAs in whole blood. A pilot methodical study

  • Popis výsledku v původním jazyce

    Background. MicroRNAs (miRNAs) are new generation biomarkers used in oncology, cardiology, metabolic syndrome, obesity or in neurology. miRNAs are short non-coding RNA molecules that regulate gene expression in eukaryotes. Aim. To compare a new commercial method for establishing miRNA (imunoassay) with a commercial kit RT qPCR. Methods. RNA was isolated from whole blood samples obtained from four healthy volunteers. The isolates were liquated and miRNA-93-Sp and miRNA-23a-3p were measured independently with commercial hsa-miR-93-Sp miREIA and hsa-miR-23a-3p miREIA, and commercial RT-qPCR kits. Results. Both miRNAs had good analytical characteristics, very good correlation with RT qPCR. The results between immunoassay and RT qPCR did not statistically differ. A method based on ELISA was faster (2 h with ELISA vs. 3 h with qPCR) and had lower CV then a method based on RT qPCR (see more text). Conclusion. MicroRNAs from blood or derived fractions are particularly interesting candidates for routine laboratory applications.The immunoassay can be performed on any device that processes the ELISA plates and is therefore available in almost every laboratory.

  • Název v anglickém jazyce

    Comparison of a new immunoassay and PCR-based method for quantification of microRNAs in whole blood. A pilot methodical study

  • Popis výsledku anglicky

    Background. MicroRNAs (miRNAs) are new generation biomarkers used in oncology, cardiology, metabolic syndrome, obesity or in neurology. miRNAs are short non-coding RNA molecules that regulate gene expression in eukaryotes. Aim. To compare a new commercial method for establishing miRNA (imunoassay) with a commercial kit RT qPCR. Methods. RNA was isolated from whole blood samples obtained from four healthy volunteers. The isolates were liquated and miRNA-93-Sp and miRNA-23a-3p were measured independently with commercial hsa-miR-93-Sp miREIA and hsa-miR-23a-3p miREIA, and commercial RT-qPCR kits. Results. Both miRNAs had good analytical characteristics, very good correlation with RT qPCR. The results between immunoassay and RT qPCR did not statistically differ. A method based on ELISA was faster (2 h with ELISA vs. 3 h with qPCR) and had lower CV then a method based on RT qPCR (see more text). Conclusion. MicroRNAs from blood or derived fractions are particularly interesting candidates for routine laboratory applications.The immunoassay can be performed on any device that processes the ELISA plates and is therefore available in almost every laboratory.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30500 - Other medical sciences

Návaznosti výsledku

  • Projekt

  • Návaznosti

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Ostatní

  • Rok uplatnění

    2019

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    BIOMEDICAL PAPERS-OLOMOUC

  • ISSN

    1213-8118

  • e-ISSN

    1804-7521

  • Svazek periodika

    1

  • Číslo periodika v rámci svazku

    163

  • Stát vydavatele periodika

    CZ - Česká republika

  • Počet stran výsledku

    6

  • Strana od-do

    39-44

  • Kód UT WoS článku

    000458362500005

  • EID výsledku v databázi Scopus

    2-s2.0-85062361913